Home › Funds › Octagon Capital Advisors LP › AVBP
Octagon Capital Advisors LP position in AVBP
ARRIVENT BIOPHARMA INC · Health Care
Octagon Capital Advisors LP reported holding 2,141,387 shares of AVBP (ARRIVENT BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$64.8M, representing 8.64% of its reported portfolio and ranking #5 among its reported holdings. Octagon Capital Advisors LP has disclosed AVBP holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Octagon Capital Advisors LP's AVBP position evolved
Octagon Capital Advisors LP first disclosed a stake in AVBP in Q1 2024 at 1,943,836 shares (US$34.7M). The position peaked in Q2 2026 at 1,971,054 shares, worth US$68.5M. Across 11 filings, Octagon Capital Advisors LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,141,387 shares valued at US$64.8M — an increase of 170,333 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 1.94M | $34.72M | New |
| Q2 2024 | 1.80M | $33.45M | Reduce |
| Q3 2024 | 1.98M | $46.45M | Add |
| Q4 2024 | 2.06M | $54.86M | Add |
| Q1 2025 | 2.06M | $38.08M | Hold |
| Q2 2025 | 1.95M | $42.37M | Reduce |
| Q3 2025 | 1.97M | $36.37M | Add |
| Q4 2025 | 1.97M | $39.66M | Hold |
| Q1 2026 | 1.97M | $45.47M | Hold |
| Q2 2026 | 1.97M | $68.47M | Hold |
| Q3 2026 | 2.14M | $64.84M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AVBP and 13F data
AVBP (ARRIVENT BIOPHARMA INC) is a Health Care company. 51 other funds we track also report a position in AVBP — the largest reported positions include MONTANOVA CAPITAL, LLC (US$149.1M), INFINITUM ASSET MANAGEMENT, LLC (US$137.0M), Hillhouse Capital (HHLR Advisors) (US$119.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AVBP
- MONTANOVA CAPITAL, LLC 4.93M sh · $149.15M · Q3 2026
- INFINITUM ASSET MANAGEMENT, LLC 4.52M sh · $136.98M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 3.93M sh · $118.97M · Q3 2026
- ORBIMED ADVISORS LLC 3.03M sh · $91.67M · Q3 2026
- Vivo Capital, LLC 1.79M sh · $54.11M · Q3 2026
- Sofinnova Investments, Inc. 1.70M sh · $51.38M · Q3 2026
- General Catalyst Group Management, LLC 1.49M sh · $45.26M · Q3 2026
- Logos Global Management LP 1.35M sh · $40.88M · Q3 2026
- Novo Holdings A/S 1.18M sh · $35.58M · Q3 2026
- HSG Holding Ltd 663.31K sh · $20.08M · Q3 2026
- Foresite Capital Management VI LLC 490.34K sh · $14.85M · Q3 2026
- Seven Fleet Capital Management LP 451.17K sh · $13.66M · Q3 2026
More on Octagon Capital Advisors LP
FAQ
How long has Octagon Capital Advisors LP held AVBP?
Octagon Capital Advisors LP has disclosed AVBP holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Octagon Capital Advisors LP's current position in AVBP?
As of Q3 2026, Octagon Capital Advisors LP holds 2.14M shares of AVBP (ARRIVENT BIOPHARMA INC), valued at $64.84M, representing 8.64% of its reported portfolio and ranking #5.
Has Octagon Capital Advisors LP been buying or selling AVBP?
In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP increased its position in AVBP. The position peaked in Q2 2026 at 1.97M shares.
Which other funds hold AVBP?
Other major institutional holders of AVBP include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Hillhouse Capital (HHLR Advisors), among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.